Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer

Clinical Cancer Research

Volumn 3, Issue 9, 1997, Pages 1615-1622

  Bochner, Bernard H ^a   Esrig, David ^a   Groshen, Susan ^a   Dickinson, Ming ^a   Weidner, Noel ^c   Nichols, Peter W ^a   Skinner, Donald G ^b   Cote, Richard J ^a,d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANGIOGENESIS; ARTICLE; BLADDER CANCER; CANCER INVASION; CYSTECTOMY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; STATISTICAL ANALYSIS; TUMOR GROWTH;

CARCINOMA, TRANSITIONAL CELL; CELL NUCLEUS; CYSTECTOMY; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GENES, P53; HUMANS; LIFE TABLES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; PROGNOSIS; RISK; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0030810781     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1997. CA Cancer J. Clin., 47: 5-27, 1997.
2. Skinner, D. G., and Lieskovsky, G. Management of invasive and high-grade bladder cancer. In: D. G. Skinner and G. Lieskovsky (eds.), Diagnosis and Management of Genitourinary Cancer, pp. 295-312. Philadelphia: W. B. Saunders Co., 1988.
3. See, W. A., and Fuller, J. R. Staging of advanced bladder cancer. Current concepts and pitfalls. Urol. Clin. North Am., 19: 663-683: 1992.
4. Esrig, D., Elmajian, D., Groshen, S., Freeman, J. A., Stein, J. P., Chen, S. C., Nichols, P. W., Skinner, D. G., Jones, P. A., and Cote, R. J. Accumulation of nuclear p53 and tumor progression in bladder cancer. N. Engl. J. Med., 331: 1259-1264, 1994.
5. Dalbagni, G., Presti, J. C., Jr, Reuter, V. E., Zhang, Z. F., Sarkis, A. S., Fair, W. R., and Cordon Cardo, C. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diagn. Mol. Pathol., 2: 4-13, 1993.
6. Sarkis, A. S., Dalbagni, G., Cordon Cardo, C., Zhang, Z. F., Sheinfeld, J., Fair, W. R., Herr, H. W., and Reuter, V. E. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J. Natl. Cancer Inst. (Bethesda), 85: 53-59, 1993.
7. Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., and Vogelstein, B. Identification of p53 gene mutations in bladder cancers and urine samples. Science (Washington DC), 252: 706-709, 1991.
8. Logothetis, C. J., Xu, H. J., Ro, J. Y., Hu, S. X., Sahin, A., Ordonez, N., and Benedict, W. F. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J. Natl. Cancer Inst. (Bethesda), 84: 1256-1261, 1992.
9. Cordon Cardo, C., Wartinger, D., Petrylak, D., Dalbagni, G., Fair, W. R., Fuks, Z., and Reuter, V. E. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J. Natl. Cancer Inst. (Bethesda), 84: 1251-1256, 1992.
10. Folkman, J., Cole, P., and Zimmerman, S. Tumor behavior in isolated perfused organs: in vitro growth and metastasis of biopsy material in rabbit thyroid and canine intestinal segment. Ann. Surg., 164: 491-502, 1966.
11. Sutherland, R. M., McCredie, J. A., and Inch, W. R. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J. Natl. Cancer Inst. (Bethesda), 46: 113-120, 1971.
12. Gimbrone, M. A., Leapman, S., Cotran, R. S., and Joh, R. Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med., 136: 261-276, 1972.
13. Srivastava, A., Laidler, P., Hughes, L. E., Woodcock, J., and Shedden, E. J. Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur. J. Cancer Clin. Oncol., 22: 1205-1209, 1986.
14. Weidner, N., Semple, J. P., Welch, W., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
15. Macchiarini, P., Fontanini, G., Hardin, M. J., Squartini, F., and Angeletti, C. A. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet, 340: 145-146, 1992.
16. Wakui, S., Furusato, M., Itoh, T., Sasaki, H., Akiyama, A., Kinoshita, I., Asano, K., Tokuda, T., Aizawa, S., and Ushigome, S. Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J. Pathol., 168: 257-262, 1992.
17. Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W., and Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol., 143: 401-409, 1993.
18. Bochner, B. H., Cote, R. J., Weidner, N., Groshen, S., Chen, S. C., Skinner, D. G., and Nichols, P. W. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J. Natl. Cancer Inst. (Bethesda), 87: 1603-1612, 1995.
19. Dickinson, A. J., Fox, S. B., Persad, R. A., Hollyer, J., Sibley, G. N., and Harris, A. L. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br. J. Urol., 74: 762-766, 1994.
20. Jaeger, T. M., Weidner, N., Chew, K., Moore, D. H., Kerschmann, R. L., Waldman, F. M., and Carroll, P. R. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J. Urol., 154: 69-71, 1995.
21. Rastinejad, F., Polverini, P. J., and Bouck, N. P. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell, 56: 345-355, 1989.
22. Dameron, K. M., Volpert, O. V., Tainsky, M. A., and Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science (Washington DC), 265: 1582-1584, 1994.
23. Bergkvist, A., Lungqvist, A., and Moberger, G. Classification of bladder tumours based on the cellular pattern. Acta Chir. Scand., 130: 371-378, 1965.
24. Hermanek, P., and Sobin, L. H. TNM classification of malignant tumors, 4th Ed., pp. 133-134. New York: Springer-Veriag, 1987.
25. Shi, S. R., Key, M. E., and Kalra, K. L. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem., 39: 741-748, 1991.
26. Bochner, B. H., Nichols, P. W., Groshen, S., Skinner, D. G., and Cote, R. J. Differential endothelial staining of the human hematopoietic progenitor cell antigen (CD34) and factor VIII antigen: utility in microvessel (angiogenesis) identification in bladder cancer. Lab. Invest., 72: 416, 1995.
27. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., and Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. (Bethesda), 84: 1875-1887, 1992.
28. Esrig, D., Spruck, C. H. D., Nichols, P. W., Chaiwun, B., Steven, K., Groshen, S., Chen, S. C., Skinner, D. G., Jones, P. A., and Cote, R. J. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am. J. Pathol., 143: 1389-1397, 1993.
29. Miller, R. G. Survival Analysis, pp. 119-140. New York: John Wiley & Sons, 1981.
30. Gaynor, J. J., Feure, E. J., Tan, C. C., and Jon, R. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J. Am. Stat. Assoc., 88: 400-409, 1993.
31. Berry, G., Kitchin, R. M., and Mock, P. A. A comparison of two simple hazard ratio estimators based on the logrank test. Stat. Med., 10: 749-755, 1991.
32. Lawless, J. F. Statistical Models and Methods for Lifetime Data., 7.2.1-7.2.2. pp. 343-371. New York: John Wiley & Sons, 1982.
33. Mantel, N., and Jaenszell, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Am. Stat. Assoc. 22: 719-748, 1959.
34. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
35. Sarkis, A. S., Dalbagni, G., Cordon Cardo, C., Melamed, J., Zhang, Z. F., Sheinfeld, J., Fair, W. R., Herr, H. W., and Reuter, V. E. Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J. Urol., 152: 388-392, 1994.
36. Grossfeld, G. D., Ginsberg, D. A., Stein, J. P., Bochner, B. H., Esrig, D., Groshen, S., Dunn, M., Nichols, P. W., Taylor, C. R., Skinner, D. G., and Cote, R. J. Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J. Natl. Cancer Inst. (Bethesda), 89: 219-227, 1997.